Nov 29, 2024
Are you up to date on the use of tropomyosin receptor kinase (TRK) inhibitors in pediatric patients with TRK fusion-positive cancers?
Credit available for this activity expires: 11/29/25
Earn Credit / Learning Objectives & Disclosures: